DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and more than 2,300 generic ingredients from more than 1,700 branded and generic pharmaceutical companies, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.
|Database preview Discount schedule Contact|
This chart shows which pharmaceutical companies face the most patent expirations this year. The drug companies facing the most patent expirations this year are Merck, Sanofi Aventis Us, Glaxosmithkline, Abbvie, Abraxis Bioscience, Genzyme, Abbott Endocrine, Boehringer Ingelheim, Merck And Co Inc, and Vyteris.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639`abc